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Summary. At present there are several grading systems for 
prostatic arcinoma. Most are difficult to reproduce. An 
objective method of grading seems to be necessary and 
could make comparisons between various groups of 
patients easier and grading more reliable. 
In the present study morphometrically estimated nu- 
clear size and variation in nuclear size are matched with 
the survival rates of 207 patients who underwent total 
perineal prostatectomy for cancer. On the basis of mor- 
phometrically estimated variation in nuclear size the 
patients could be divided into two groups with significant- 
ly differing survival rates. In this way it was possible to 
split the group of patients with grade 2 carcinoma 
(Mostofi's grading system) into two groups of patients 
with significantly different survival rates. The survival 
rates in these two groups did not differ significantly from 
those in the patients with Grade 1 and Grade 3 tumors 
respectively. 
The results are discussed in the light of the recent 
literature on the subject. Morphometry seems to be a 
valuable tool in grading prostatic ancer. 
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Since Broders' first report on grading epitheliomas of the 
lip in the early 1920's [5] many investigators have tried to 
correlate the histological picture of prostatic arcinomas 
with the clinical course of the disease [9, 13]. This has 
resulted in the introduction of many grading systems for 
prostate cancer, but only few of them found wide accept- 
ance. Several reasons can be indicated for this phe- 
nomenon: 
First prostatic carcinoma often presents in various 
histological patterns and several of such patterns can be 
found in the same tumor and even in the same slide. The 
different patterns can vary considerably in appearance, 
ranging from well differentiated parts, almost resembling 
normal prostatic glandular tissue, to undifferentiated 
parts in which absolutely no features of the original 
prostatic tissue are recognizable. Within these different 
patterns or "tumor formations" cytological characteristics 
may vary in the same way from regularly arranged 
cuboidal cells without any nuclear pleomorphism to 
disorderly arranged cells with nuclei that show consider- 
able variation in size, shape and staining. Furthermore it 
is not uncommon that in rather well-differentiated parts 
of a tumor cytological characteristics show marked ab- 
normalities, uggesting a very malignant tumor, while on 
the other hand hardly any nuclear pleomorphism ay be 
found in tumors with a solid pattern of growth. It is 
difficult to take account of all these variable features in 
one grading system. 
A second reason for the poor acceptance of grading 
systems is their poor reproducibility. Most grading sys- 
tems produce the best results in the hands of the person 
who developed the system, while in other hands the 
reproducibility is rather disappointing [10, 12, 14]. 
A third reason is the subjectivity in interpreting the 
results of the various grading systems. Generally there is 
no problem in identifying the low grade and high grade 
tumors, whatever system is used. The problem lies in the 
large group of patients that neither have clear high grade 
nor evident low grade tumors and are by exclusion placed 
in the poorly defined intermediate group of patients 
whose prognosis apparently is not clearly defined. This is 
the truly problematic group. 
In 1975 Mostofi [13] proposed a grading system that 
seemed to be quite easy to apply. In the first place he 
clearly defined differentiation as the tendency of a tumor 
to form glands and the characteristics of these glands as 
compared to normal prostatic glands. Anaplasia was 
defined as a scaled assessment of nuclear characteristics 
such as nuclear size, hyperchromatism, pleomorphism, 
presence of nucleoli and mitoses. This system seemed to 
solve the problem of classifying tumors that on one hand 
may grow in solid sheets with no gland formation and 
with a slight cellular atypia as opposed to the cytological- 
ly more anaplastic tumors forming well developed 
glands. 
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Table 1. Number of tumor formations 
1 formation 113 patients 113 formations 
2 formations 152 patients 304 formations 
3 formations 73 patients 219 formations 
4 formations 8 patients 32 formations 
Total 346 patients 668 formations 
Table 2. Tumor stage in 207 patients 
Stage No. patients % 
A 28 13.5 
B 112 54.1 
C 64 30.9 
unknown 3 1.5 
In an extensive study Schroeder and co-workers [16] 
evaluated the prognostic weight of each of the parameters 
in Mostofi's grading system and they came to the con- 
clusion that only glandular differentiation, uclear pleo- 
morphism and amount  of tumor seen in the slide were 
important parameters in relation to the prognosis of the 
disease. The presence of mitoses also showed importance, 
but the vast majority of prostatic arcinomas contain no 
or very few mitoses. Schroeder and co-workers proposed a
simplification of Mostofi's grading system, showing its 
application in a large series of 346 cases of prostatic 
carcinoma, all graded by Mostofi [17]. 
In 1979, when the present study started, the question 
came up whether the parameter variation in nuclear size 
and shape (nuclear pleomorphism) could be objectivated 
in some way. It has been shown for other tumors and 
benign tissues [15] that with morphometry,  using a 
planimeter in combinat ion with a computerized evalu- 
ation of the measurements, structures can be quantif ied 
for several parameters such as surface area, circumference 
(perimeter), relative volumes, shape descriptions etc. It 
was hoped that with such an image analysing system it 
could be possible to have an objective tool in grading 
carcinoma nd to diminish the subjectivity and variabil ity 
resulting from the use of the conventional grading sys- 
tems. The initial results were reported in 1982 [3] and 1983 
[2, 4]. 
Independently from our work a similar project was 
carried out at the Brady Urological Institute in Baltimore. 
It was shown that the so-called "nuclear roundness factor" 
correlated very well with prognosis [6, 7, 8]. 
In the present study nuclear variation in size and shape 
has been estimated in 207 cases of prostatic carcinoma 
with a computerized semi-automatic mage analysing 
system. The results have been correlated with survival and 
Mostofi's grading system. 
matched with the clinical data of 346 patients. This has been 
reported elsewhere [16]. 
For various reasons not all of the 346 sets of histological slides 
were suitable for morphometry. Fourty-six patients received hor- 
monal treatment before total prostatectomy, causing squamous 
metaplasia toa greater or lesser extent. In most cases the presence of 
metaplasia was no problem for conventional grading, but these 
patients were excluded from morphometry. The quality of the 
histological slides of 20 patients was too poor for morphometrical 
purposes. The slides of 10 patients had been lost during the last 
years. In five slides there was a significant squamous metaplasia, 
suggesting the use of hormones, although there was no note in the 
patient chart on the use of hormonal treatment. Fifty-eight slides 
could not be analyzed for various reasons, for instance because the 
amount of tumor in the slides was too small to obtain enough nuclei 
to process or the contours of the nuclei were too vague for accurate 
tracing, or the slides that were at our disposal did not contain tumor 
at all. This resulted in 207 cases that were available and suitable for 
morphometry. The number of slides per patient varied from 1 to 24 
with an average of 3 slides per case. The slides were almost all from 
the same institution (Good Samaritan Hospital, Los Angeles, Ca). A 
few slides came from another hospital (Hollywood Presbyterian 
Hospital, Hollywood, Ca). 
The clinical stages of carcinoma ofthese 207 patients are given in 
Table 2. 
Patient identification on the slides was only by number and 
morphometry was therefore carried out in a blind fashion. 
Morphometry 
The morphometrical analysis was performed with a semi-automatic 
computerized image analysing system (Videoplan, Kontron). Basi- 
cally this system consists of three components: 
1. a graphic tablet 
2. a cursor or a pen, and 
3. a desk computer 
Both the graphic tablet and the cursor or pen are connected tothe 
computer. Besides these, a printer/plotter is connected to the 
computer. 
Material and methods 
Patients 
In a series of 484 patients on whom the late Dr. Elmer Belt 
performed a total perineal prostatectomy for cancer the patient 
charts were reviewed retrospectively. In 346 cases histological slides 
from the prostatectomy specimens were available for review. These 
tumors were all regraded by Dr. Mostofi without knowledge of the 
follow-up of the patients. Most of the tumors consisted of a varying 
number of morphologically different formations (e.g. tubular, 
cribriform, solid). As Table 1 shows their number varied from one to 
four per patient and a total of 668 tumor formations have been 
The graphic tablet and cursor 
The Videoplan graphic tablet (or digitizer tablet) operates on the 
magnetostrictive principle. The area of the tablet is divided in a 
horizontal nd vertical way by a mesh of ferromagnetic wires, laid on 
a substrate beneath the tablet surface, spaced at regular intervals in 
X and Y direction. This mesh of wires provides a permanent 
magnetic field. In addition the wires conduct electronically induced 
magnetic pulses in both directions. These pulses are emitted at a 
constant frequency and travel at a constant speed, unaffected by 
environmental conditions. The cursor has two crosswires, indicating 
the exact point on the tablet. In the centre of these crosswires a light- 
emitting diode (LED) is mounted, to make the centre of the 
Table 3. Effect of magnification on accuracy of digitizing (each 
nucleus is digitized at least 50X) 
Magnifi- mean standard coefficient of 
cation area (g2) deviation variation 
400X 76.65 4.55 5.94 
25.32 2.69 10.62 
59.89 4.15 6.93 
10.31 0.49 4.75 
22.45 2.12 9.44 
5.73 0.25 4.36 
630X 78.58 3.13 3.98 
23.84 1.36 5.70 
5.93 0.19 3.20 
10.10 0.34 3.37 
56.18 3.19 5.68 
78.76 3.30 4.19 
Table 4. Lymphocyte measurements during several years (the maxi- 
mum deviation from the mean is 5%) 
Year mean nuclear area S.D. 
1939 15.79 2.78 
1944 17.23 2.87 
1945 17.41 3.47 
1955 17.09 3.62 
1965 15.47 2.43 
1969 16.75 2.60 
1970 16.30 3.24 
Mean 16.58 
Table 5. Effect of number of nuclei on accuracy 
Number of nuclei Mean nuclear area 
25 38.00 
50 32.33 
75 34.22 
100 33.12 
125 32.25 
150 31.85 
200 31.96 
275 32.06 
400 32.52 
crosswires visible in the microscope. When positioned or moved on 
the surface of the tablet, the cursor intercepts X and Y pulses 
continuously through a receiver coil to derive coordinate locations. 
Based on the parameters selected, the microprocessor continuously 
calculates and updates the individual measurements until terminat- 
ed. When a line is drawn, for example around a nucleus, the 
computer can calculate the surface area, the circumference (per- 
imeter) and several other parameters. The resolution of the system is 
0.1 ram. However, as the average diameter of a nucleus, projected on 
the graphic tablet is about 15 mm, this resolution constitutes less 
than 1% of the total diameter. 
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The microscope 
The microscope is a regular Zeiss microscope. It has 10X wide field 
eyepieces and plan achromat objectives (magnification: 4X, 10X, 
40X and 63X). On the microscope a drawing attachment is mounted 
(Zeiss 474620), so that the LED in the centre of the cursor can be seen 
together with the normal field of vision of the microscope. The 
microscope was arranged in such a way that when the cursor was 
placed in the centre of the graphic tablet, its LED was seen in the 
centre of the field of vision of the microscope. In order to see the 
LED clearly, the light of the microscope had to be adjusted to a 
convenient level. Also the room illumination had to be dimmed to a 
lower level. 
Accuracy and reproducibility 
Before starting the actual morphometric measurements the accuracy 
and reproducibility of the technique was studied: 
1. What is the best magnification of the microscope? 
2. Could there be artefacts due to different handling of the material 
in different laboratories? 
3. How many nuclei should be digitized per tumor formation? 
4. Should one measure nuclei n all available slides or is limitation to 
one slide per patient possible? 
5. Is one field of vision representative for a given tumor-formation 
or should one go randomly through the slides? 
6. How accurate is the mechanism of tracing nuclei? 
1: To establish the best suitable magnification of the microscope we 
digitized several nuclei of one tumor repeatedly using several 
magnifications. The results are shown in Table 3. 
The largest possible magnification was optimal. Although a 
higher magnification would probably give better esults, the highest 
power dry system was used for practical reasons. The total 
magnification of the microscope was 63 N 10 = 630X. 
To examine the accuracy of measuring with this magnification a 
circle in an eyepiece grid was traced several times and a coefficient of 
variation in surface area of 3.94% was found. This is within 
acceptable limits. 
2: It is a well known fact that fixation and laboratory handling of 
tissue causes hrinkage of all structures to a certain amount. This is 
true for fresh and old material. To investigate the effect of tissue 
handling in the two different laboratories during several years, we 
digitized lymphocytes in the slides of several patients from each 
laboratory and representing several years. Slide preparation at 
various points in time was checked because it is unknown to us 
whether material handling is still the same now as it was in 1939. 
Table 4 shows that there is in fact no significant difference between 
the effect of fixation and tissue handling for the years from 1939 
through 1970. 
3: To establish the number of nuclei necessary in each tumor 
formation up to 400 nuclei were digitized in one tumor formation. 
As shown in table 5, the values for the mean nuciear area did not 
change significantly above a number of 125 nuclei. On the basis of 
this result it was decided to use for the routine of this study 150 nuclei 
per tumor formation. 
4 and 5: Regarding the number of slides and the areas in the slides to 
be digitized an analysis of variance (ANOVA) [1] was used. With this 
method the tumors of six patients were digitized, three tumors from 
patients who lived for a long time after total prostatectomy without 
any evidence of recurrence and three tumors from patients who died 
very soon after total prostatectomy of metastatic disease. Of each of 
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Table 6. Analysis of variance Coefficient of variation for nuclear area (Varea) 
Patients field of 
vision 
(prognosis) 
Slide 1 Slide 2 Slide 3 
Day 1 Day 2 Day 1 Day 2 Day 1 Day 2 
A 1 27.52 16.97 28.35 24.48 22.96 15.43 
(good) 2 25.99 19.71 22.40 18.67 24.45 32.76 
B 1 18.57 24.75 25.43 27.39 28.14 19.97 
(good) 2 29.21 16.20 21.73 19.24 19.26 18.60 
C 1 20.57 20.40 21.67 22.54 23.00 23.96 
(good) 2 24.98 22.37 21.46 21.65 19.60 23.80 
D 1 42.70 21.52 19.58 19.58 27.13 25.89 
(poor) 2 20.27 28.50 29.28 30.94 24.21 27.52 
E 1 27.81 24.55 27.61 32.43 29.81 32.12 
(poor) 2 17.16 23.71 26.38 25.62 23.99 21.57 
F 1 22.48 26.10 32.68 25.08 75.42 67.24 
(poor) 2 23.99 24.80 38.76 27.31 43.14 24.67 
4 X rE X area 
Table 7. ANOVA Final calculation FORMpe - (perimeter)2 
Category DF diff(Z )42)  Variance F-test 
diff/DF 
total 71 6,279.05 88.44 
days 1 88.11 88.11 1.20 
fields of vision 1 161.79 161.79 2.20 
slides 2 333.38 166.69 2.27 
patients 1 849.89 849.89 11.58 
remainder 66 4,895.88 73.42 
these six tumors 3 slides and in each slide two randomly chosen fields 
of vision were digitized. The location of the fields of vision was 
recorded precisely by means of the crosstable of the microscope. 
Several days later the whole procedure was repeated, digitizing 
exactly the same fields of vision in the same slides. The results are 
summarized in Table 6. 
From these values variances were calculated for the three 
different slides, the two fields of vision, the two separate days and the 
two groups of patients. The results are shown in Table 7. 
After entering these values in the F-table [1] it was shown that 
there were no significant differences between the measurements in 
the different slides or fields of vision. Also there was no significant 
difference between measurements ondifferent days. The two groups 
of patients however, showed a significant difference in variance. 
Accordingly, the method of morphometry and the coefficient of 
variation for nuclear area should allow a good differentiation 
between the various patients. 
Our conclusion was that one could digitize anywhere in the slides 
and use as many or as few fields of vision as needed to obtain the 
proper amount of nuclei to be digitized. 
Methods of measurements (digitizing) 
Before the measurements started several parameters were selected in 
the computer software program. These parameters were: 
1. surface area, 
2. perimeter, and two so-called form factors: 
3. FORMpe, also called circularity index. This form factor is given 
by the equation: 
In the case of an exact circle the value for FORMpe equals 1. In all 
other cases FORMpe is less than 1. The more the shape of a structure 
deviates from the circle, the less the value for FORMpe becomes. 
4. FORMen, also called ellipticity index. This form factor is given by 
the equation: 
Forme,=B/A 
Circles : Formetl=l 
All other structures: Formetl<l 
As for FORMpe, the value for FORM~u equals 1 in case of a circle. In 
all other structures the value for FORMen becomes less than 1. 
Both form factors are suitable to objectivate the shape of the nuclei, 
while the area and perimeter were measures for nuclear size. These 
four parameters were measured and calculated for 150 nuclei n each 
tumor formation. When a tumor consisted of only one tumor 
formation, only 150 nuclei were measured in that tumor. When a 
tumor consisted of two or three formations, the number of nuclei 
digitized were 300 and 450 per tumor respectively. From these 150 
nuclei a mean value for each parameter and a standard eviation 
were calculated. 
Statistics 
The main goal was not to objectivate size and shape of the nuclei, but 
the variation in size and shape. The variation of the form factors was 
calculated by dividing the standard eviation by the mean value. In 
this way a coefficient of variation was calculated for each of the 
parameters in each of the tumor formations. The coefficient of 
variation is indicated by the capital etter "V'.  
In this way the coefficient of variation for area (Varea) was 
obtained as a standard for the variation in nuclear size and the 
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Fig. 1. Comparison between survival and time to first recurrence. 
The patterns of the curves are identical. The survival curve is 
corrected for intercurrent or unknown causes of death. In two 
patients it was not known when they developed metastases 
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Fig. 2. The patients are divided morphometrically into two groups 
with significantly differing corrected survival rates (p < 0.01) 
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Fig. 3. The patients are divided according to Grade (Mostofi system) 
Table 8. Morphometrically estimated variation in nuclear size 
garea  N No .  deaths  No. deaths % 
from of 
cancer deaths 
<34% 155 140 31 22.1 
_> 34% 52 48 22 45.8 
coefficients of variation for FORMpe and for FORMell (V FORMpe 
and V FORMen) as a standard for the variation in nuclear shape. 
In each tumor formation 150 nuclei were digitized and for each 
nucleus the values for area, perimeter, FORMp~ and FORM~n were 
calculated. Furthermore the computer calculated the mean values 
and the standard eviations. After finishing digitizing the values 
were all stored on disks and the results were printed out. The 
procedure was repeated for each tumor formation. At the end the 
coefficient of variation was calculated by dividing the standard 
deviation by the mean. In the case of more than one tumor 
formation per tumor the highest value for V was used for further 
evaluation. 
Most results are presented as survival curves. These curves are 
calculated according to Kaplan and Meier [11]. The survival curves 
are corrected for intercurrent, tumor unrelated and unknown causes 
of death. In this way the curves show the impact of death from 
carcinoma more clearly without confusing the picture with the 
relatively high number of intercurrent deaths. For the evaluation of
the differences between the curves the Logrank test was used. 
We used death as an endpoint of study and not recurence of 
disease because all patients who had recurrence oftheir disease were 
dead at the time of the last review. Most of them indeed died of 
prstatic arcinoma and only seven (11.8 %) died of other causes than 
prostatic ancer (causes of death in these men were: cardiovascular: 
2, cerebrovascular: 1, murder: 1, other cancer: 3). It was shown that 
the curves did not change in a significant way when time to 
recurrence was used instead of time to death (Fig. 1). Of course the 
curve for recurrence of disease isshifted somewhat to the left, but the 
slopes of the curves are identical. 
Results  
With the morphometrical ly estimated variation in nu- 
clear size (Varea) it was possible to split the whole group 
of 207 patients in two subgroups with a different prog- 
nosis. One group of patients with a Varea < 34% and a 
second group of patients with a Varea ~ 34%. The cut-off 
point of 34% was found empirically. The first larger 
group consists of 155 patients. In this group there were 
31 patients who died of carcinoma. The second group, 
counting 52 patients, showed death from carcinoma in 22 
patients. The difference between the two groups is signifi- 
cant (p < 0.01, Table 8) 
Graphical ly the corrected survival rates of the two 
groups of patients are shown in Fig. 2. As can be seen from 
this figure even after ten years there is a fair chance of 
dying of carcinoma. Also here the difference between the 
two groups is significant (Logrank test, p < 0.01). 
Figure 3 shows the survival rates of the same 207 
patients, divided into three groups according to grade 
(Mostofi system). As can be expected the patients with a 
grade 1 tumor had the best prognosis. In the whole group 
only two patients died of carcinoma nd after 93 months 
there was no death of tumor in this group. Patients with 
grade 3 tumors do worst, even after 200 months patients 
died of prostatic arcinoma. The largest group of patients 
(n = 138) have grade 2 tumors and show an intermediate 
course of disease. However, also in this group after 15 
years patients till died of prostatic arcinoma (see Table 
9). 
When the group of patients with grade 2 tumors was 
divided according to morphometrical  measurements, wo 
groups of patients with significantly differing survival 
rates (p < 0.01) were identified (Fig. 4). However, the 
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Table 9. Corrected survival of 207 patients, divided according to 
grade 
Grade No. 5-years 10-years 15-years 20-years 
patients 
1 28 100% 88% 88% 88% 
2 138 91% 79% 70% 64% 
3 41 59% 47% 39% 33% 
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Fig. 4. The group of patients with Grade 21 tumors is divided 
morphometrically into two groups with significantly differing 
survival rates 
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Fig. 5. Mean nuclear area 207 patients are divided into two groups 
according to prognosis (death from prostatic ancer) 
patients with grade 2 tumors:and Varea < 34% did not 
show a significantly differing survl~al rate from those with 
grade 1 tumors, while the patientgwith grade 2 tumors and 
a Var~a --> 34% had survival rates not differing from the 
patients with grade 3 tumors. The intermediate group of 
patients with grade 2 tumors could be divided into two 
groups: one with a prognosis almost equal to those with 
Grade 1 tumors and one with a prognosis almost equal to 
those with Grade 3 tumors, 
Besides the variation in nuclear size also the mean 
nuclear size showed some correlation with the prognosis. 
In the group of 53 patients who died of prostatic 
carcinoma the tumors had a mean nuclear surface area of 
51.4 p2, while the mean nuclear size in the tumors of the 
remainder of the patients was 39.6 g2. The difference is 
significant, but as Fig. 5 shows there is an almost complete 
overlap of the two groups. 
Iil the group of 140 patients with a mean nuclear size 
< 50 p2 twenty-six patients (18.6%) died of prostatic ar- 
cinoma. This was the case in 27 patients (40.3%) with a 
mean nuclear size of_> 50 g2. This difference is significant 
(p < 0.01). 
Neither V FORMp~ nor V FORMell allowed to identify 
patients with different survival patterns. In now way was it 
possible to correlate these parameters with prognosis. 
Discussion 
Besides clinical stage the histopathological grade of a 
tumor plays an important role in establishing the prog- 
nosis of prostatic arcinoma. It is a well established fact 
that nuclear pleomorphism is one of the most important 
parameters in grading prostatic arcinoma. Most grading 
systems, especially those developed in the last two decen- 
nia use this parameter besides glandular differentiation 
and a varying number of other parameters. In an extensive 
study on 346 cases of prostatic arcinoma, all graded by 
Dr. Mostofi using his grading system [13], Schroeder and 
co-workers [ 16] found that in grading especially glandular 
differentiation a d nuclear pleomorphism play an import- 
ant role in the evaluation of the malignant potential of the 
tumor. Only the presence of mitoses may have an 
additional effect on the prognosis, but all other parame- 
ters as for instance the aspect of the cytoplasm, the 
presence or absence of nucleoli, the presence or absence of 
nuclear vacuoles, the number of various tumor forma- 
tions, nuclear size do not have any weight in the prognosis 
of the tumors and may as well be omitted to simplify the 
system of grading. 
Some reports how that grading of prostatic arcinoma 
is a somewhat subjective matter. Generally there are little 
problems in recognizing the true high grade and the true 
low grade tumors. The problems arise with the tumors 
that are neither high grade nor low grade. These tumors 
are by exclusion placed in a large and poorly defined 
intermediate group. However, in this group there may be 
large differences in prognosis, indicating that although 
these tumors all seem to have an intermediate grade, they 
are not uniform in behaviour. It is mainly the large group 
of Grade 2 tumors which presents difficulties in predicting 
prognosis. In this light it is strange that attempts to 
objectivate grading of prostatic arcinoma have started 
rather late. 
The first investigators who quantitated nuclear charac- 
teristics and correlated their findings with tumor grade 
were St6ber and Schmidt [18] who measured nuclear area 
morphometrically and found a correlation with nuclear 
size and tumor grade. 
In 1982 Diamond and colleagues [6, 7] presented their 
results with a new shape descriptor, called Nuclear 
Roundness Factor, and they were able to identify in a 
blind way two groups of patients who were cured by 
radical surgery or who would later die of cancer. Their 
system was shown to be 100 per cent accurate in this small 
series of  27 patients. There were no false positives and no 
false negatives in the prediction of death from carcinoma 
of the prostate. In an attempt o reproduce these findings 
the nuclear oundness factor was calculated using the data 
of our patients. Surprisingly the values for nuclear 
roundness did not correlate well with corrected survival. 
Even an attempt to digitize some of our histological 
material on Diamond's  equipment failed to identify 
nuclear roundness as a useful parameter in our hands. 
There was a very good correlation between the calculated 
nuclear oundness factor and the FORMpe, but both failed 
to show any correlation with the prognosis. 
It has not become clear to us why in our hands the 
nuclear oundness factor was not an important prognostic 
parameter. In an attempt o resolve this discrepancy one 
of us (JB) and one of the investigators from the Brady 
Urological Institute digitized on two occasions some 
geometrical figures with known sizes and shapes (circles, 
ellipses, squares, triangles and hexagons). It was noticed 
that each investigator's own results were easily reproduci- 
ble, but that it was not possible to reproduce the results of 
each other. It was also found that the intra-observer 
variations were largest in digitizing the smaller figures. 
In order to evaluate whether a difference in equipment 
might be the cause of  the fact that nuclear oundness was 
not prognostic in our hands, some of our slides were 
digitized on Diamond's  equipment. Also on Diamond's  
equipment in our hands nuclear oundness did not predict 
prognosis. In five patients who did not develop metastases 
up to a mean time of 147.8 months after total prostatec- 
tomy the mean nuclear roundness varied from 1,024 to 
1,085 with an average of 1,054.4. A group of 17 patients 
who developed metastases after a mean interval of 34.9 
months after total prostatectomy showed a mean value for 
nuclear roundness of 1,049.2 (range: 1,020-1,079). In the 
same groups of  patients the mean values for Varea were 
34.1% in the group with a good prognosis (range:28.3- 
40.0%) and 36.0% in the group with a poor prognosis 
(range: 24.9-52.8 %). 
Digitizing of  some of our slides by D. D iamond also 
failed to show any correlation of nuclear roundness with 
survival. The reasons for the discrepancy of results is not 
clear, but it may be concluded that the accuracy of the 
digitizing equipment does not play as important a role as 
suggested by Diamond [7]. 
In conclusion it can be said that objectivation of 
nuclear size is possible and that the variation of  this 
parameter gives a good correlation with survival. Patients 
with tumors that show a large variation in nuclear size will 
have a poorer prognosis than patients whose tumor nuclei 
do not show large variation in size. Morphometry can help 
in making a decision whether the patient might have a 
poor prognosis and may need aggressive therapy. Mor- 
phometry cannot replace the conventional grading sys- 
tems at this time, but it can add objectivity to grading. 
More work has to be done to standardize the system of 
morphometry  to obtain interchangeable r sults. 
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